| Nome |
# |
|
Redox homeostasis as a target for new antimycobacterial agents, file e18b865d-2863-1ee6-e053-3a05fe0ae544
|
115
|
|
ATM splicing variants as biomarkers for low dose dexamethasone treatment of A-T, file e18b865d-5e7d-1ee6-e053-3a05fe0ae544
|
68
|
|
Ex vivo encapsulation of dexamethasone sodium phosphate into human autologous erythrocytes using fully automated biomedical equipment, file 478b0f85-8522-45f1-a347-d7ac860ab3e1
|
63
|
|
Reengineering red blood cells for cellular therapeutics and diagnostics, file e80caf92-bc81-4333-8b86-280810908b01
|
31
|
|
Dexamethasone improves redox state in ataxia telangiectasia cells by promoting an NRF2-mediated antioxidant response, file e18b865d-70c9-1ee6-e053-3a05fe0ae544
|
22
|
|
Ongoing Developments and Clinical Progress in Drug-Loaded Red Blood Cell Technologies, file e18b865d-10ae-1ee6-e053-3a05fe0ae544
|
14
|
|
Efficient Cocaine Degradation by Cocaine Esterase-Loaded Red Blood Cells, file e18b865d-2dc0-1ee6-e053-3a05fe0ae544
|
12
|
|
A new therapy prevents intellectual disability in mouse with phenylketonuria, file 3ab020de-099e-43b6-8803-8251938cd977
|
8
|
|
Red Blood Cell Membrane Processing for Biomedical Applications, file e18b865c-ec14-1ee6-e053-3a05fe0ae544
|
8
|
|
Effect of macrophage depletion on viral DNA rebound following antiretroviral therapy in a murine model of AIDS (MAIDS), file e18b865b-8045-1ee6-e053-3a05fe0ae544
|
7
|
|
Engineering new metabolic pathways in isolated cells for the degradation of guanidinoacetic acid and simultaneous production of creatine., file e18b865d-bd33-1ee6-e053-3a05fe0ae544
|
7
|
|
Engineering erythrocytes for the modulation of drugs' and contrasting agents' pharmacokinetics and biodistribution, file b3e7407a-f92c-4284-9de6-9fb334a00d2b
|
6
|
|
Immunophilin-loaded erythrocytes as a new delivery strategy for immunosuppressive drugs, file e18b865b-85aa-1ee6-e053-3a05fe0ae544
|
6
|
|
Adherence and intracellular survival within human macrophages of Enterococcus faecalis isolates from coastal marine sediment, file e18b865b-aa4d-1ee6-e053-3a05fe0ae544
|
6
|
|
Activation of NRF2 by dexamethasone in ataxia telangiectasia cells involves KEAP1 inhibition but not the inhibition of p38, file e18b865c-d619-1ee6-e053-3a05fe0ae544
|
6
|
|
Preclinical developments of enzyme-loaded red blood cells, file e18b865d-36a0-1ee6-e053-3a05fe0ae544
|
5
|
|
Erythrocyte-mediated delivery of recombinant enzymes, file e18b865b-d59b-1ee6-e053-3a05fe0ae544
|
4
|
|
Targeting antiviral nucleotide analogues to macrophages, file e18b865b-dfc1-1ee6-e053-3a05fe0ae544
|
4
|
|
Preclinical and clinical developments in enzyme-loaded red blood cells: an update, file e0613fcf-4ee5-4bf5-92f2-161eb0a872d6
|
3
|
|
Prolonged islet allograft survival in diabetic mice upon macrophage depletion by clodronate-loaded erythrocytes, file e18b865b-7aa9-1ee6-e053-3a05fe0ae544
|
3
|
|
Erythrocyte-based drug delivery, file e18b865b-7b91-1ee6-e053-3a05fe0ae544
|
3
|
|
Improved cellular uptake of functionalized single-walled carbon nanotubes, file e18b865b-83fe-1ee6-e053-3a05fe0ae544
|
3
|
|
Long-term treatment with autologous red blood cells loaded with dexamethasone 21-phosphate in pediatric patients affected by steroid-dependent crohn disease and ulcerative colitis, file e18b865c-07e1-1ee6-e053-3a05fe0ae544
|
3
|
|
Drug delivery through phagocytosis of red blood cells, file e18b865c-09db-1ee6-e053-3a05fe0ae544
|
3
|
|
Dexamethasone improves redox state in ataxia telangiectasia cells by promoting an NRF2-mediated antioxidant response, file e18b865d-6b42-1ee6-e053-3a05fe0ae544
|
3
|
|
Myelin basic protein recovery during PKU mice lifespan and the potential role of microRNAs on its regulation, file f6856a9e-9cfb-43fa-95b2-324201f3dc0b
|
3
|
|
Erythrocyte-mediated delivery of dexamethasone in patients with chronic obstructive pulmonary disease, file e18b865b-7aff-1ee6-e053-3a05fe0ae544
|
2
|
|
Targeting nucleotide dimers containing antiviral nucleosides, file e18b865b-7c0d-1ee6-e053-3a05fe0ae544
|
2
|
|
Targeting antiretroviral nucleosode analogues in phosphorylated form to macrophages. In vitro and in vivo studies., file e18b865b-7c0f-1ee6-e053-3a05fe0ae544
|
2
|
|
Inhibition of murine AIDS by a heterodinucleotide of azidothymidine and 9-(R)-2-(phosphonomethoxypropyl)adenine, file e18b865b-8378-1ee6-e053-3a05fe0ae544
|
2
|
|
Approaches to erythrocyte-mediated drug delivery, file e18b865b-88aa-1ee6-e053-3a05fe0ae544
|
2
|
|
Erythrocyte-mediated delivery of phenylalanine ammonia lyase for the treatment of phenylketonuria in BTBR-Pahenu2 mice, file e18b865b-8c68-1ee6-e053-3a05fe0ae544
|
2
|
|
Label-free quantification of Tacrolimus in biological samples by atomic force microscopy, file e18b865b-ad35-1ee6-e053-3a05fe0ae544
|
2
|
|
Macrophage depletion by Clodronate-loaded erythrocytes, file e18b865b-ea5e-1ee6-e053-3a05fe0ae544
|
2
|
|
Enterococcus faecium ST17 from coastal marine sediment carryng transferable multidrug resistance plasmids, file e18b865b-f79d-1ee6-e053-3a05fe0ae544
|
2
|
|
Macrophages depletion induced by clodronate-loaded erythrocytes, file e18b865c-092d-1ee6-e053-3a05fe0ae544
|
2
|
|
Engineering erythrocytes for the modulation of drugs' and contrasting agents' pharmacokinetics and biodistribution, file e18b865d-71e3-1ee6-e053-3a05fe0ae544
|
2
|
|
In vivo effects of dexamethasone on blood gene expression in ataxia telangiectasia, file e18b865d-8972-1ee6-e053-3a05fe0ae544
|
2
|
|
Intellectual Disability and Brain Creatine Deficit: Phenotyping of the Genetic Mouse Model for GAMT Deficiency, file e18b865d-a18a-1ee6-e053-3a05fe0ae544
|
2
|
|
Observation of erythrocyte dynamics in the retinal capillaries and choriocapillaris using ICG-loaded erythrocyte ghost cells, file e18b865b-7aaa-1ee6-e053-3a05fe0ae544
|
1
|
|
Erythrocyte-mediated delivery of dexamethasone in patients with mild-to-moderate ulcerative colitis, refractory to mesalamine: a randomized, controlled study, file e18b865b-7aab-1ee6-e053-3a05fe0ae544
|
1
|
|
New synthetic glutathione derivatives with increased antiviral activities, file e18b865b-7ab0-1ee6-e053-3a05fe0ae544
|
1
|
|
Periodic treatment with autologous erythrocytes loaded with dexamethasone 21-phosphate for fistulizing pediatric Crohn's disease: case report, file e18b865b-7b02-1ee6-e053-3a05fe0ae544
|
1
|
|
Low doses of dexamethasone constantly delivered by autologous erythrocytes slow the progression of lung disease in cystic fibrosis patients, file e18b865b-7b05-1ee6-e053-3a05fe0ae544
|
1
|
|
Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides, file e18b865b-7b06-1ee6-e053-3a05fe0ae544
|
1
|
|
FIV infection of macrophages: in vitro and in vivo inhibition by dideoxycytidine-5'-triphosphate., file e18b865b-7b07-1ee6-e053-3a05fe0ae544
|
1
|
|
The polymorphism of multi-drug resistance 1 gene (MDR1) does not influence the pharmacokinetics of dexamethasone loaded into autologous erythrocytes of patients with inflammatory bowel disease, file e18b865b-7c06-1ee6-e053-3a05fe0ae544
|
1
|
|
High throughput HPLC-ESI-MS method for the quantitation of dexamethasone in blood plasma., file e18b865b-7c08-1ee6-e053-3a05fe0ae544
|
1
|
|
Erythrocyte engineering for drug delivery and targeting., file e18b865b-7c09-1ee6-e053-3a05fe0ae544
|
1
|
|
A new acyclic heterodinucleotide active against human immunodeficiency virus and herpes simplex virus, file e18b865b-7c0a-1ee6-e053-3a05fe0ae544
|
1
|
|
Erythrocytes-mediated delivery of Dexamethasone in steroid-dependent IBD patients – A pilot uncontrolled study, file e18b865b-7c0b-1ee6-e053-3a05fe0ae544
|
1
|
|
Effect of listeriolysin O-loaded erythrocytes on Mycobacterium avium replication within macrophages, file e18b865b-7c0e-1ee6-e053-3a05fe0ae544
|
1
|
|
A new homodimer of acyclovir as a prodrug with increased solubility and antiviral activity, file e18b865b-805d-1ee6-e053-3a05fe0ae544
|
1
|
|
Cytotoxic activity of 2-Fluoro-ara-AMP and 2-Fluoro-ara-AMP-loaded erythrocytes against human breast carcinoma cell lines., file e18b865b-8301-1ee6-e053-3a05fe0ae544
|
1
|
|
Erythrocytes as carriers of reduced glutathione (GSH) in the treatment of retroviral infections, file e18b865b-8308-1ee6-e053-3a05fe0ae544
|
1
|
|
2',3'-Dideoxycytidine induced drug resistance in human cells, file e18b865b-830d-1ee6-e053-3a05fe0ae544
|
1
|
|
Long term treatment with autologous red blood cells loaded with dexamethasone 21-phosphate in pediatric patients affected by steroid dependent Crohn’s disease, file e18b865b-8367-1ee6-e053-3a05fe0ae544
|
1
|
|
Erythrocyte-mediated delivery of a new homodinucleotide active against human immunodeficiency virus and herpes simplex virus, file e18b865b-8376-1ee6-e053-3a05fe0ae544
|
1
|
|
Pharmacokinetic and antiretroviral activity in mice of oral [P(1),P(2)-bis[2-(adenin-9-yl)ethoxymethyl]phosphonate], a prodrug of 9-(2-phosphonylmethoxyethyl)adenine, file e18b865b-8383-1ee6-e053-3a05fe0ae544
|
1
|
|
Encapsulation, metabolism and release of 2-fluoro-ara-AMP from human erythrocytes., file e18b865b-83bc-1ee6-e053-3a05fe0ae544
|
1
|
|
2',3'-Dideoxycytidine metabolism in a new drug-resistant cell line, file e18b865b-83bf-1ee6-e053-3a05fe0ae544
|
1
|
|
Metabolism, mitochondrial uptake and toxicity of 2’,3’-dideoxycytidine, file e18b865b-83dd-1ee6-e053-3a05fe0ae544
|
1
|
|
Drug delivery by red blood cells, file e18b865b-85ab-1ee6-e053-3a05fe0ae544
|
1
|
|
Inhibition of HIV-1 replication in macrophages by a heterodinucleotide of lamivudine and tenofovir, file e18b865b-863b-1ee6-e053-3a05fe0ae544
|
1
|
|
Inhibition of HIV-1 replication in macrophages by red blood cell-mediated delivery of a heterodinucleotide of lamivudine and tenofovir, file e18b865b-863c-1ee6-e053-3a05fe0ae544
|
1
|
|
Erythrocyte as a novel delivery vehicle for biologics: from enzymes to nucleic acid-based therapeutics, file e18b865b-8950-1ee6-e053-3a05fe0ae544
|
1
|
|
Macrophage Depletion by Free Bisphosphonates and Zoledronate-Loaded Red Blood Cells, file e18b865b-8be9-1ee6-e053-3a05fe0ae544
|
1
|
|
Erythrocytes-mediated delivery of dexamethasone 21-phosphate in steroid-dependent ulcerative colitis: a randomized, double-blind sham-controlled study, file e18b865b-8d7b-1ee6-e053-3a05fe0ae544
|
1
|
|
Cell-based drug delivery, file e18b865c-07e2-1ee6-e053-3a05fe0ae544
|
1
|
|
Red Blood Cell-Based Delivery of Drugs and Nanomaterials for Therapeutic and Diagnostic Applications, file e18b865c-0877-1ee6-e053-3a05fe0ae544
|
1
|
|
Erythrocytes as a controlled drug delivery system: clinical evidences, file e18b865c-0927-1ee6-e053-3a05fe0ae544
|
1
|
|
Redox homeostasis as a target for new antimycobacterial agents, file e18b865d-ad7f-1ee6-e053-3a05fe0ae544
|
1
|
| Totale |
475 |